Shanghai Rendu Biotechnology Past Earnings Performance
We're still processing the latest earnings report of this company
Past criteria checks 2/6
Shanghai Rendu Biotechnology's earnings have been declining at an average annual rate of -29.1%, while the Medical Equipment industry saw earnings growing at 6.4% annually. Revenues have been declining at an average rate of 20.1% per year. Shanghai Rendu Biotechnology's return on equity is 2.4%, and it has net margins of 13.3%.
Key information
-29.1%
Earnings growth rate
-33.5%
EPS growth rate
| Medical Equipment Industry Growth | 16.0% |
| Revenue growth rate | -20.1% |
| Return on equity | 2.4% |
| Net Margin | 13.3% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
A Look At The Intrinsic Value Of Shanghai Rendu Biotechnology Co., Ltd. (SHSE:688193)
Oct 16
There Are Some Holes In Shanghai Rendu Biotechnology's (SHSE:688193) Solid Earnings Release
May 06We Like These Underlying Return On Capital Trends At Shanghai Rendu Biotechnology (SHSE:688193)
Apr 17What Shanghai Rendu Biotechnology Co., Ltd.'s (SHSE:688193) 29% Share Price Gain Is Not Telling You
Mar 08Revenue & Expenses Breakdown
How Shanghai Rendu Biotechnology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 171 | 23 | 108 | 43 |
| 31 Mar 24 | 170 | 18 | 113 | 42 |
| 31 Dec 23 | 164 | 8 | 119 | 41 |
| 30 Sep 23 | 181 | -9 | 122 | 38 |
| 30 Jun 23 | 214 | -9 | 143 | 38 |
| 31 Mar 23 | 249 | 0 | 154 | 35 |
| 31 Dec 22 | 304 | 23 | 158 | 34 |
| 30 Sep 22 | 309 | 37 | 157 | 34 |
| 30 Jun 22 | 322 | 54 | 150 | 30 |
| 31 Mar 22 | 299 | 62 | 128 | 27 |
| 31 Dec 21 | 292 | 65 | 128 | 26 |
| 31 Dec 20 | 250 | 61 | 103 | 23 |
| 31 Dec 19 | 99 | 4 | 76 | 13 |
| 31 Dec 18 | 69 | -32 | 83 | 10 |
Quality Earnings: 688193 has a large one-off gain of CN¥20.0M impacting its last 12 months of financial results to 30th June, 2024.
Growing Profit Margin: 688193 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 688193 has become profitable over the past 5 years, growing earnings by -29.1% per year.
Accelerating Growth: 688193 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 688193 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-8.8%).
Return on Equity
High ROE: 688193's Return on Equity (2.4%) is considered low.